1-(3-AMINOPROPYL) SUBSTITUTED CYCLIC AMINE COMPOUNDS, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITIONS AND USES THEREOF
申请人:SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES
公开号:US20170044187A1
公开(公告)日:2017-02-16
Provided are 1-(3-aminopropyl) substituted cyclic amine compounds as represented by formula (I), pharmaceutically acceptable salts, enantiomers, diastereoisomers, racemates and mixtures thereof, and a method of synthesizing said 1-(3-aminopropyl) substituted cyclic amine compounds by using aromatic heterocyclic formaldehyde as raw material. Said compounds can be used as CCR 5 antagonist for the treatment of HIV infection.
The present invention relates to 1-(azolin-2-yl)-amino-2-aryl-1-hetaryl-ethane compounds (I) and 1-(aminothiocarbonylamino)-2-aryl-1-hetaryl-ethane compounds (II) and their salts which are useful for combating animal pest, in particular insects, arachnids and nematodes. Furthermore, the present invention relates to a method for combating animal pests selected from insects, arachnids and nematodes, and to agricultural compositions for combating animal pests. Furthermore, the present invention relates to veterinary compositions for combating animal pests.
COMPOUND HAVING BET INHIBITORY ACTIVITY AND PREPARATION METHOD AND USE THEREFOR
申请人:Shanghai Haihe Pharmaceutical Co., Ltd.
公开号:EP3750885A1
公开(公告)日:2020-12-16
The invention relates to the field of pharmaceutical chemistry. Specifically, the present invention relates to a series of BET (bromodomain and extra-terminal domain) inhibitors having a novel structure, particularly inhibitors targeting BRD4 (Bromodomain-containing protein 4), and a preparation method and use therefor. The structure thereof is shown in the following general formula (I). Said compounds or a stereoisomer, racemate, geometric isomer, tautomer, prodrug, hydrate, solvate, or crystal form thereof, or a pharmaceutically acceptable salt thereof, and the pharmaceutical compsosition thereof can be used for the treatment and/or prevention of related diseases mediated by bromodomain proteins.
[EN] COMPOUND HAVING BET INHIBITORY ACTIVITY AND PREPARATION METHOD AND USE THEREFOR<br/>[FR] COMPOSÉ PRÉSENTANT UNE ACTIVITÉ INHIBITRICE DE BET, SON PROCÉDÉ DE PRÉPARATION ET SON UTILISATION<br/>[ZH] 具有BET抑制活性的化合物及其制备方法和用途
申请人:SHANGHAI HAIHE PHARMACEUTICAL CO LTD
公开号:WO2019154329A1
公开(公告)日:2019-08-15
本发明属于药物化学领域。具体地,本发明涉及一系列具有新型结构的BET(bromodomain and extra-terminal domain)抑制剂,尤其是靶向BRD4(Bromodomain-containing protein 4)的抑制剂,及其制备方法和用途。其结构如下列通式(I)所示。这些化合物或其立体异构体、外消旋物、几何异构体、互变异构体、前药、水合物、溶剂化物、晶型或其药学上可接受的盐及药物组合物,可用于治疗或/和预防由溴结构域蛋白介导的相关疾病。
A Facile Synthesis of <i>N</i>-Sulfonyl and <i>N</i>-Sulfinyl Aldimines under Barbier-Type Conditions
作者:Renhua Fan、Dongming Pu、Fengqi Wen、Yang Ye、Xiaoli Wang
DOI:10.1021/jo800009t
日期:2008.5.1
A convenient synthesis of N-sulfonyl- and N-sulfinylimines by the condensation of aldehydes with sulfonyl or sulfinyl amides in the presence of benzyl bromide and zinc dust at room temperature under the Barbier-type conditions is reported. The procedure is lauded by its simplicity and adaptability to aromatic, alpha,beta-unsaturated, and aliphatic aldehydes.